EU Commission issues winter Covid warning

The European Commission is demanding EU states take action to stop the increase in Covid cases prior to the winter and fall months.

This the evening of Friday (2 September) the agency published a 15-page strategy document that aims to fight the virus that’s killing around 2,300 people every day across all of the EU as well as Iceland, Liechtenstein, and Norway.

“The Covid-19 pandemic is still very much with us. Together, we must act in a coordinated way to avoid another surge of cases,” said Stella Kyriakides, EU health commissioner, on Twitter.

The paper suggests the following, among others EU states boost the uptake of vaccines and provide additional boosters to those at risk, such as people over 60 or who are at the risk of developing any serious illness.

The study reveals a threefold increase of cases in the summer months. It has since decreased, however, it remains high in people who are over 65.

The paper also notes that the rate of vaccine consumption has not significantly changed.

A little more than 14 percent of adults are unvaccinated, and just 35 percent of them have not yet received their first booster shot, it states.

The warning by the commission follows an announcement of the European Medicines Agency (EMA) that it had approved two modified versions of Comirnaty as well as Spikevax vaccines.

The vaccines are developed to fight different strains of the SARS-CoV-2 virus in order to increase the immune system.

“Both can be used to re-vaccinate people from 12 years of age we have had their first two shots of primary vaccination,” the FDA’s Marco Cavaleri told reporters on Friday.

The two vaccines that are adaptive can be used to revaccinate regardless of the kind of jabs people have had before, he added.

He also said that both vaccines trigger powerful immune responses to Omicron BA 1 and the original virus in those who have been vaccinated.

“In particular, they were more effective at triggering immune responses against the BA.1 sub-variant than the original vaccines,” the researcher said.